Member Exclusive

A united effort for rare disease drug discovery: an exclusive interview with Dr David Swinney

In honor of Rare Disease Day (Feb 29th) MedChemNet is in conversation with Dr David Swinney, CEO of the Institute for Rare and Neglected Diseases Drug Discovery (iRND3)

Go to the profile of Stella Bennett
Feb 29, 2016

Please sign in or register for FREE

No comments yet.